Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers